Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)

Femme et Homme

| Pays :
Italy
United States
| Organes :
| Spécialités :

Extrait

This study will assess the efficacy of subsequent protease inhibitor (PI)-containing therapy in subjects who have acquired HIV-1 protease mutations whilst receiving a GW433908 (fosamprenavir)-containing regimen.

Critère d'inclusion

Infection, Human Immunodeficiency Virus I ,HIV infection

Liens

nct
ictrp